Table 1.
Patient characteristics.
| Characteristics | No. of cases | % of cases |
|---|---|---|
| Age | ||
| <40 | 7 | 22.6 |
| 40–49 | 8 | 25.8 |
| 50–59 | 9 | 29.0 |
| ≥60 | 7 | 22.6 |
| Race | ||
| Non-Hispanic Black | 7 | 22.6 |
| Non-Hispanic White | 18 | 58.1 |
| Hispanic | 2 | 6.4 |
| Asian/Pacific Islander | 4 | 12.9 |
| Disease status | ||
| Previously untreated | 0 | 0.0 |
| Recurrent disease | 31 | 100.0 |
| Performance status | ||
| 0 | 25 | 80.6 |
| 1 | 5 | 16.1 |
| 2 | 1 | 3.2 |
| Prior radiotherapy | ||
| Yes | 3 | 9.7 |
| No | 28 | 90.3 |
| Prior immunotherapy | ||
| Yes | 1 | 3.2 |
| No | 30 | 96.8 |
| Prior chemotherapy | ||
| Yes | 24 | 77.4 |
| No | 7 | 22.6 |
| Prior hormone therapy | ||
| Yes | 3 | 9.7 |
| No | 28 | 90.3 |
| Pretreatment Inhibin (pg/mL) | ||
| ≤10 | 12 | 38.7 |
| 11–100 | 10 | 32.2 |
| >100 | 1 | 3.2 |